Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the report of Fresenius Medical Care AG & Co. KGaA (the “Company”) on Form 6-K furnished for the month of August 2011 containing its unaudited financial statements as of June 30, 2011 and for the six-month periods ending June 30, 2011 & 2010, as submitted to the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Dr. Ben J. Lipps, Chief Executive Officer and Michael Brosnan, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

By:  /s/  Dr. Ben J. Lipps

Dr. Ben J. Lipps

Chief Executive Officer and

Chairman of the Management Board of the

General Partner

August 19, 2011

By:  /s/  Michael Brosnan

Michael Brosnan

Chief Financial Officer and

member of the Management Board of the

General Partner

August 19, 2011